Welcome to our dedicated page for KRAKacquisition news (Ticker: KRAQU), a resource for investors and traders seeking the latest updates and insights on KRAKacquisition stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect KRAKacquisition's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of KRAKacquisition's position in the market.
KRAKacquisition Corp (NASDAQ:KRAQU) closed an upsized IPO of 34,500,000 units priced at $10.00 per unit, including the full exercise of a 4,500,000-unit over-allotment, generating gross proceeds of $345 million before fees.
Units began trading on January 28, 2026. Each unit contains one Class A ordinary share and one-fourth of a warrant; each full warrant is exercisable for one Class A share at $11.50. Separate trading of shares and warrants is expected under KRAQ and KRAQW. The company is a SPAC formed to pursue a business combination and has not selected a target. Santander US Capital Markets acted as sole underwriter; the Form S-1 became effective on January 27, 2026.
KRAKacquisition Corp (NASDAQ:KRAQU) priced an upsized $300,000,000 initial public offering of 30,000,000 units at $10.00 per unit. Units begin trading on January 28, 2026 under KRAQU; expected IPO close is January 29, 2026, subject to customary conditions.
Each unit contains one Class A ordinary share and one-fourth of a redeemable warrant (warrant exercise price $11.50). The company granted underwriters a 45-day option for 4,500,000 additional units to cover over-allotments.
FAQ
What is the current stock price of KRAKacquisition (KRAQU)?
